Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-02-09 @ 7:15 AM
Study NCT ID:
NCT02159820
Status:
UNKNOWN
Last Update Posted:
2014-06-10
First Post:
2014-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06
Start Date Type:
None
Primary Completion Date:
2024-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06
Completion Date Type:
ESTIMATED
First Submit Date:
2014-06-01
First Submit QC Date:
None
Study First Post Date:
2014-06-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-09
Last Update Post Date:
2014-06-10
Last Update Post Date Type:
ESTIMATED